Potent long-acting rhFGF21 analog for treatment of diabetic nephropathy in db/db and DIO mice

por Zhao, Longwei, Wang, Huiyan, Xie, Junjun, Chen, Zilu, Li, Xiaokun, Niu, Jianlou
Publicado 2017

Fibroblast growth factor 1 ameliorates adipose tissue inflammation and systemic insulin resistance via enhancing adipocyte mTORC2/Rictor signal

por Zhao, Longwei, Fan, Miaojuan, Zhao, Lijun, Yun, Hongyan, Yang, Yan, Wang, Chen, Qin, Di
Publicado 2020

Production of bioactive recombinant human myeloid‐derived growth factor in Escherichia coli and its mechanism on vascular endothelial cell proliferation

por Zhao, Longwei, Feng, Shuang, Wang, Shen, Fan, Miaojuan, Jin, Wei, Li, Xianjing, Wang, Chen, Yang, Yong
Publicado 2019

Paracrine-endocrine FGF chimeras as potent therapeutics for metabolic diseases

por Zhao, Longwei, Niu, Jianlou, Lin, Huan, Zhao, Jing, Liu, Yang, Song, Zihui, Xiang, Congshang, Wang, Xiaojie, Yang, Yong, Li, Xiaokun, Mohammadi, Moosa, Huang, Zhifeng
Publicado 2019

Paracrine FGFs target skeletal muscle to exert potent anti-hyperglycemic effects

por Ying, Lei, Wang, Luyao, Guo, Kaiwen, Hou, Yushu, Li, Na, Wang, Shuyi, Liu, Xingfeng, Zhao, Qijin, Zhou, Jie, Zhao, Longwei, Niu, Jianlou, Chen, Chuchu, Song, Lintao, Hou, Shaocong, Kong, Lijuan, Li, Xiaokun, Ren, Jun, Li, Pingping, Mohammadi, Moosa, Huang, Zhifeng
Publicado 2021